The Enigmatic Drug Binding Site for Sodium Channel Inhibitors

Current Molecular Pharmacology

Volumn 3, Issue 3, 2010, Pages 129-144

  Mike, Arpad ^a   Lukacs, Peter ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Antiarrhythmic; Anticonvulsant; Binding site; Blocker; Local anesthetic; Model; Mutagenesis; Sodium channel

Indexed keywords

AMITRIPTYLINE; ASPARAGINE; BUPIVACAINE; COCAINE; ETIDOCAINE; FLECAINIDE; GLYCINE; ISOLEUCINE; KETAMINE; LAMOTRIGINE; LIDOCAINE; MEMBRANE LIPID; MEXILETINE; PAROXETINE; PETHIDINE; PHENYTOIN; POTASSIUM CHANNEL; PRENYLAMINE; QUINIDINE; RANOLAZINE; SERINE; SERTRALINE; SODIUM; SODIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL NAV1.2; SODIUM CHANNEL NAV1.4; SODIUM CHANNEL NAV1.5; SODIUM CHANNEL NAV1.8; TRIFLUOPERAZINE; UNINDEXED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONFORMATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DRUG BINDING SITE; ELECTRIC POTENTIAL; PRIORITY JOURNAL; SENSOR; SITE DIRECTED MUTAGENESIS; SODIUM TRANSPORT; VESTIBULE;

EID: 78650005671     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467211003030129     Document Type: Article

References (105)

1. Hodgkin, A.L.; Huxley, A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol., 1952, 117, 500-544.
2. Catterall, W.A.; Mackie, K. Local anesthetics. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th ed.; Companies, M.-H. Ed.; New York, 2006; pp. 369-386.
3. Kyle, D.J.; Ilyin, V.I. Sodium channel blockers. J. Med. Chem., 2007, 50, 2583-2588.
4. Ogata, N.; Ohishi, Y. Molecular diversity of structure and function of the voltage-gated Na+ channels. Jpn. J. Pharmacol., 2002, 88, 365-377.
5. Zuliani, V.; Patel, M.K.; Fantini, M.; Rivara, M. Recent advances in the medicinal chemistry of sodium channel blockers and their therapeutic potential. Curr. Top. Med. Chem., 2009, 9, 396-415.
6. England, S.; de Groot, M.J. Subtype-selective targeting of voltagegated sodium channels. Br. J. Pharmacol., 2009, 158, 1413-1425.
7. Tarnawa, I.; Bolcskei, H.; Kocsis, P. Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases. Recent Pat. CNS Drug Discov., 2007, 2, in press.
8. Catterall, W.A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron, 2000, 26, 13-25.
9. Catterall, W.A.; Goldin, A.L.; Waxman, S.G. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev., 2005, 57, 397-409.
10. Goldin, A.L. Evolution of voltage-gated Na(+) channels. J. Exp. Biol., 2002, 205, 575-584.
11. Bezanilla, F. Ion channels: from conductance to structure. Neuron, 2008, 60, 456-468.
12. Bjelkmar, P.; Niemela, P.S.; Vattulainen, I.; Lindahl, E. Conformational changes and slow dynamics through microsecond polarized atomistic molecular simulation of an integral Kv1.2 ion channel. PLoS Comput. Biol., 2009, 5, e1000289.
13. Ulbricht, W. Sodium channel inactivation: molecular determinants and modulation. Physiol. Rev., 2005, 85, 1271-1301.
14. Patlak, J. Molecular kinetics of voltage-dependent Na+ channels. Physiol. Rev., 1991, 71, 1047-1080.
15. Hu, H.; Martina, M.; Jonas, P. Dendritic mechanisms underlying rapid synaptic activation of fast-spiking hippocampal interneurons. Science, 2010, 327, 52-58.
16. Wang, S.Y.; Mitchell, J.; Moczydlowski, E.; Wang, G.K. Block of inactivation-deficient Na+ channels by local anesthetics in stably transfected mammalian cells: evidence for drug binding along the activation pathway. J. Gen. Physiol., 2004, 124, 691-701.
17. Hille, B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J. Gen. Physiol., 1977, 69, 497-515.
18. Starmer, C.F.; Grant, A.O.; Strauss, H.C. Mechanisms of use dependent block of sodium channels in excitable membranes by local anesthetics. Biophys. J., 1984, 46, 15-27.
19. nd.; Andersen, O.S. Docosahexaenoic acid alters bilayer elastic properties. Proc. Natl. Acad. Sci. USA, 2007, 104, 9638-9643.
20. Xiao, Y.F.; Ke, Q.; Wang, S.Y.; Auktor, K.; Yang, Y.; Wang, G.K.; Morgan, J.P.; Leaf, A. Single point mutations affect fatty acid block of human myocardial sodium channel alpha subunit Na+ channels. Proc. Natl. Acad. Sci. USA, 2001, 98, 3606-3611.
21. Kim, H.I.; Kim, T.H.; Shin, Y.K.; Lee, C.S.; Park, M.; Song, J.H. Anandamide suppression of Na+ currents in rat dorsal root ganglion neurons. Brain Res., 2005, 1062, 39-47.
22. Nicholson, R.A.; Liao, C.; Zheng, J.; David, L.S.; Coyne, L.; Errington, A.C.; Singh, G.; Lees, G. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. Brain Res., 2003, 978, 194-204.
23. Zhang, J.; Hadlock, T.; Gent, A.; Strichartz, G.R. Tetracainemembrane interactions: effects of lipid composition and phase on drug partitioning, location; ionization. Biophys. J., 2007, 92, 3988-4001.
24. Hendry, B.M.; Elliott, J.R.; Haydon, D.A. Further evidence that membrane thickness influences voltage-gated sodium channels. Biophys. J., 1985, 47, 841-845.
25. Seeman, P. The membrane actions of anesthetics and tranquilizers. Pharmacol. Rev., 1972, 24, 583-655.
26. Bruhova, I.; Tikhonov, D.B.; Zhorov, B.S. Access and binding of local anesthetics in the closed sodium channel. Mol. Pharmacol., 2008, 74, 1033-1045.
27. Long, S.B.; Tao, X.; Campbell, E.B.; MacKinnon, R. Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature, 2007, 450, 376-382.
28. Schmidt, D.; Jiang, Q.X.; MacKinnon, R. Phospholipids and the origin of cationic gating charges in voltage sensors. Nature, 2006, 444, 775-779.
29. Bokesch, P.M.; Post, C.; Strichartz, G. Structure-activity relationship of lidocaine homologs producing tonic and frequency dependent impulse blockade in nerve. J. Pharmacol. Exp. Ther., 1986, 237, 773-781.
30. Brown, M.L.; Brown, G.B.; Brouillette, W.J. Effects of log P and phenyl ring conformation on the binding of 5-phenylhydantoins to the voltage-dependent sodium channel. J. Med. Chem., 1997, 40, 602-607.
31. Brown, M.L.; Zha, C.C.; Van Dyke, C.C.; Brown, G.B.; Brouillette, W.J. Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel. J. Med. Chem., 1999, 42, 1537-1545.
32. Ehring, G.R.; Moyer, J.W.; Hondeghem, L.M. Quantitative structure activity studies of antiarrhythmic properties in a series of lidocaine and procainamide derivatives. J. Pharmacol. Exp. Ther., 1988, 244, 479-492.
33. Wang, Y.; Jones, P.J.; Batts, T.W.; Landry, V.; Patel, M.K.; Brown, M.L. Ligand-based design and synthesis of novel sodium channel blockers from a combined phenytoin-lidocaine pharmacophore. Bioorg. Med. Chem., 2009, 17, 7064-7072.
34. Koshland, D.E. Application of a Theory of Enzyme Specificity to Protein Synthesis. Proc. Natl. Acad. Sci. USA, 1958, 44, 98-104.
35. Fozzard, H.A.; Lee, P.J.; Lipkind, G.M. Mechanism of local anesthetic drug action on voltage-gated sodium channels. Curr. Pharm. Des., 2005, 11, 2671-2686.
36. Nau, C.; Wang, G.K. Interactions of local anesthetics with voltagegated Na+ channels. J. Membr. Biol., 2004, 201, 1-8.
37. Yamaoka, K.; Vogel, S.M.; Seyama, I. Na+ channel pharmacology and molecular mechanisms of gating. Curr. Pharm. Des., 2006, 12, 429-442.
38. Li, H.L.; Galue, A.; Meadows, L.; Ragsdale, D.S. A molecular basis for the different local anesthetic affinities of resting versus open and inactivated states of the sodium channel. Mol. Pharmacol., 1999, 55, 134-141.
39. Yarov-Yarovoy, V.; Brown, J.; Sharp, E.M.; Clare, J.J.; Scheuer, T.; Catterall, W.A. Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na(+) channel alpha subunit. J. Biol. Chem., 2001, 276, 20-27.
40. Ragsdale, D.S.; McPhee, J.C.; Scheuer, T.; Catterall, W.A. Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science, 1994, 265, 1724-1728.
41. Lipkind, G.M.; Fozzard, H.A. Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels. Mol. Pharmacol., 2005, 68, 1611-1622.
42. Scheib, H.; McLay, I.; Guex, N.; Clare, J.J.; Blaney, F.E.; Dale, T.J.; Tate, S.N.; Robertson, G.M. Modeling the pore structure of voltage-gated sodium channels in closed, open; fast-inactivated conformation reveals details of site 1 toxin and local anesthetic binding. J. Mol. Model., 2006, 12, 813-822.
43. Tikhonov, D.B.; Zhorov, B.S. Modeling P-loops domain of sodium channel: homology with potassium channels and interaction with ligands. Biophys. J., 2005, 88, 184-197.
44. Wang, S.Y.; Tikhonov, D.B.; Zhorov, B.S.; Mitchell, J.; Wang, G.K. Serine-401 as a batrachotoxin-and local anesthetic-sensing residue in the human cardiac Na+ channel. Pflugers Arch., 2007, 454, 277-287.
45. Hanck, D.A.; Nikitina, E.; McNulty, M.M.; Fozzard, H.A.; Lipkind, G.M.; Sheets, M.F. Using lidocaine and benzocaine to link sodium channel molecular conformations to state-dependent antiarrhythmic drug affinity. Circ. Res., 2009, 105, 492-499.
46. Muroi, Y.; Chanda, B. Local anesthetics disrupt energetic coupling between the voltage-sensing segments of a sodium channel. J. Gen. Physiol., 2009, 133, 1-15.
47. Ahern, C.A.; Eastwood, A.L.; Dougherty, D.A.; Horn, R. Electrostatic contributions of aromatic residues in the local anesthetic receptor of voltage-gated sodium channels. Circ. Res., 2008, 102, 86-94.
48. Kimbrough, J.T.; Gingrich, K.J. Quaternary ammonium block of mutant Na+ channels lacking inactivation: features of a transition intermediate mechanism. J. Physiol., 2000, 529(Pt 1), 93-106.
49. Zamponi, G.W.; French, R.J. Dissecting lidocaine action: diethylamide and phenol mimic separate modes of lidocaine block of sodium channels from heart and skeletal muscle. Biophys. J., 1993, 65, 2335-2347.
50. Bai, C.X.; Glaaser, I.W.; Sawanobori, T.; Sunami, A. Involvement of local anesthetic binding sites on IVS6 of sodium channels in fast and slow inactivation. Neurosci. Lett., 2003, 337, 41-45.
51. McPhee, J.C.; Ragsdale, D.S.; Scheuer, T.; Catterall, W.A. A critical role for transmembrane segment IVS6 of the sodium channel alpha subunit in fast inactivation. J. Biol. Chem., 1995, 270, 12025-12034.
52. Yarov-Yarovoy, V.; McPhee, J.C.; Idsvoog, D.; Pate, C.; Scheuer, T.; Catterall, W.A. Role of amino acid residues in transmembrane segments IS6 and IIS6 of the Na+ channel alpha subunit in voltage dependent gating and drug block. J. Biol. Chem., 2002, 277, 35393-35401.
53. Kondratiev, A.; Tomaselli, G.F. Altered gating and local anesthetic block mediated by residues in the I-S6 and II-S6 transmembrane segments of voltage-dependent Na+ channels. Mol. Pharmacol., 2003, 64, 741-752.
54. Browne, L.E.; Blaney, F.E.; Yusaf, S.P.; Clare, J.J.; Wray, D. Structural determinants of drugs acting on the Nav1.8 channel. J. Biol. Chem., 2009, 284, 10523-10536.
55. O'Leary, M.E.; Chahine, M. Cocaine binds to a common site on open and inactivated human heart (Na(v)1.5) sodium channels. J. Physiol., 2002, 541, 701-716.
56. Sunami, A.; Glaaser, I.W.; Fozzard, H.A. Structural and gating changes of the sodium channel induced by mutation of a residue in the upper third of IVS6, creating an external access path for local anesthetics. Mol. Pharmacol., 2001, 59, 684-691.
57. Wang, G.K.; Quan, C.; Wang, S. A common local anesthetic receptor for benzocaine and etidocaine in voltage-gated mu1 Na+ channels. Pflugers Arch., 1998, 435, 293-302.
58. Ramos, E.; O'Leary, M.E. State-dependent trapping of flecainide in the cardiac sodium channel. J. Physiol., 2004, 560, 37-49.
59. Wang, G.K.; Quan, C.; Wang, S.Y. Local anesthetic block of batrachotoxin-resistant muscle Na+ channels. Mol. Pharmacol., 1998, 54, 389-396.
60. Wright, S.N.; Wang, S.Y.; Wang, G.K. Lysine point mutations in Na+ channel D4-S6 reduce inactivated channel block by local anesthetics. Mol. Pharmacol., 1998, 54, 733-739.
61. Nau, C.; Wang, S.Y.; Strichartz, G.R.; Wang, G.K. Point mutations at N434 in D1-S6 of mu1 Na(+) channels modulate binding affinity and stereoselectivity of local anesthetic enantiomers. Mol. Pharmacol., 1999, 56, 404-413.
62. Wang, S.Y.; Wang, G.K. A mutation in segment I-S6 alters slow inactivation of sodium channels. Biophys. J.,1997, 72, 1633-1640.
63. Wang, S.Y.; Barile, M.; Wang, G.K. Disparate role of Na(+) channel D2-S6 residues in batrachotoxin and local anesthetic action. Mol. Pharmacol., 2001, 59, 1100-1107.
64. Wang, S.Y.; Nau, C.; Wang, G.K. Residues in Na(+) channel D3- S6 segment modulate both batrachotoxin and local anesthetic affinities. Biophys. J.,2000, 79, 1379-1387.
65. Ragsdale, D.S.; McPhee, J.C.; Scheuer, T.; Catterall, W.A. Common molecular determinants of local anesthetic, antiarrhythmic; anticonvulsant block of voltage-gated Na+ channels. Proc. Natl. Acad. Sci. USA, 1996, 93, 9270-9275.
66. Mujtaba, M.G.; Wang, S.Y.; Wang, G.K. Prenylamine block of Nav1.5 channel is mediated via a receptor distinct from that of local anesthetics. Mol. Pharmacol., 2002, 62, 415-422.
67. Liu, H.; Atkins, J.; Kass, R.S. Common molecular determinants of flecainide and lidocaine block of heart Na+ channels: evidence from experiments with neutral and quaternary flecainide analogues. J. Gen. Physiol., 2003, 121, 199-214.
68. Smith, J.A.; Amagasu, S.M.; Hembrador, J.; Axt, S.; Chang, R.; Church, T.; Gee, C.; Jacobsen, J.R.; Jenkins, T.; Kaufman, E. Evidence for a multivalent interaction of symmetrical, N-linked, lidocaine dimers with voltage-gated Na+ channels. Mol. Pharmacol., 2006, 69, 921-931.
69. Yamagishi, T.; Xiong, W.; Kondratiev, A.; Velez, P.; Mendez-Fitzwilliam, A.; Balser, J.R.; Marban, E.; Tomaselli, G.F. Novel molecular determinants in the pore region of sodium channels regulate local anesthetic binding. Mol. Pharmacol., 2009, 76, 861-871.
70. Sunami, A.; Dudley, S.C. Jr.; Fozzard, H.A. Sodium channel selectivity filter regulates antiarrhythmic drug binding. Proc. Natl. Acad. Sci. USA, 1997, 94, 14126-14131.
71. Tsang, S.Y.; Tsushima, R.G.; Tomaselli, G.F.; Li, R.A.; Backx, P.H. A multifunctional aromatic residue in the external pore vestibule of Na+ channels contributes to the local anesthetic receptor. Mol. Pharmacol., 2005, 67, 424-434.
72. Chiamvimonvat, N.; Perez-Garcia, M.T.; Ranjan, R.; Marban, E.; Tomaselli, G.F. Depth asymmetries of the pore-lining segments of the Na+ channel revealed by cysteine mutagenesis. Neuron, 1996, 16, 1037-1047.
73. Tsushima, R.G.; Li, R.A.; Backx, P.H. Altered ionic selectivity of the sodium channel revealed by cysteine mutations within the pore. J. Gen. Physiol., 1997, 109, 463-475.
74. Benitah, J.P.; Chen, Z.; Balser, J.R.; Tomaselli, G.F.; Marban, E. Molecular dynamics of the sodium channel pore vary with gating: interactions between P-segment motions and inactivation. J. Neurosci., 1999, 19, 1577-1585.
75. Kambouris, N.G.; Hastings, L.A.; Stepanovic, S.; Marban, E.; Tomaselli, G.F.; Balser, J.R. Mechanistic link between lidocaine block and inactivation probed by outer pore mutations in the rat micro1 skeletal muscle sodium channel. J. Physiol., 1998, 512(Pt 3), 693-705.
76. Li, R.A.; Tsushima, R.G.; Kallen, R.G.; Backx, P.H. Pore residues critical for mu-CTX binding to rat skeletal muscle Na+ channels revealed by cysteine mutagenesis. Biophys. J., 1997, 73, 1874-1884.
77. Yang, Y.C.; Hsieh, J.Y.; Kuo, C.C. The external pore loop interacts with S6 and S3-S4 linker in domain 4 to assume an essential role in gating control and anticonvulsant action in the Na(+) channel. J. Gen. Physiol., 2009, 134, 95-113.
78. Tikhonov, D.B.; Zhorov, B.S. Sodium channels: ionic model of slow inactivation and state-dependent drug binding. Biophys. J., 2007, 93, 1557-1570.
79. Todt, H.; Dudley, S.C. Jr.; Kyle, J.W.; French, R.J.; Fozzard, H.A. Ultra-slow inactivation in mu1 Na+ channels is produced by a structural rearrangement of the outer vestibule. Biophys. J., 1999, 76, 1335-1345.
80. Xiong, W.; Farukhi, Y.Z.; Tian, Y.; Disilvestre, D.; Li, R.A.; Tomaselli, G.F. A conserved ring of charge in mammalian Na+ channels: a molecular regulator of the outer pore conformation during slow inactivation. J. Physiol., 2006, 576, 739-754.
81. Riddall, D.R.; Leach, M.J.; Garthwaite, J. A novel drug binding site on voltage-gated sodium channels in rat brain. Mol. Pharmacol., 2006, 69, 278-287.
82. Kuo, C.C.; Chen, R.S.; Lu, L.; Chen, R.C. Carbamazepine inhibition of Neuron,al Na+ currents: quantitative distinction from phenytoin and possible therapeutic implications. Mol. Pharmacol., 1997, 51, 1077-1083.
83. Kuo, C.C.; Lu, L. Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones. Br. J. Pharmacol., 1997, 121, 1231-1238.
84. Yang, Y.C.; Kuo, C.C. An inactivation stabilizer of the Na+ channel acts as an opportunistic pore blocker modulated by external Na+. J. Gen. Physiol., 2005, 125, 465-481.
85. Sunami, A.; Glaaser, I.W.; Fozzard, H.A. A critical residue for isoform difference in tetrodotoxin affinity is a molecular determinant of the external access path for local anesthetics in the cardiac sodium channel. Proc. Natl. Acad. Sci. USA, 2000, 97, 2326-2331.
86. Qu, Y.; Rogers, J.; Tanada, T.; Scheuer, T.; Catterall, W.A. Molecular determinants of drug access to the receptor site for antiarrhythmic drugs in the cardiac Na+ channel. Proc. Natl. Acad. Sci. USA, 1995, 92, 11839-11843.
87. Lee, P.J.; Sunami, A.; Fozzard, H.A. Cardiac-specific external paths for lidocaine, defined by isoform-specific residues, accelerate recovery from use-dependent block. Circ. Res., 2001, 89, 1014-1021.
88. Sasaki, K.; Makita, N.; Sunami, A.; Sakurada, H.; Shirai, N.; Yokoi, H.; Kimura, A.; Tohse, N.; Hiraoka, M.; Kitabatake, A. Unexpected mexiletine responses of a mutant cardiac Na+ channel implicate the selectivity filter as a structural determinant of antiarrhythmic drug access. Mol. Pharmacol., 2004, 66, 330-336.
89. Sato, C.; Ueno, Y.; Asai, K.; Takahashi, K.; Sato, M.; Engel, A.; Fujiyoshi, Y. The voltage-sensitive sodium channel is a bell-shaped molecule with several cavities. Nature, 2001, 409, 1047-1051.
90. Liu, G.; Yarov-Yarovoy, V.; Nobbs, M.; Clare, J.J.; Scheuer, T.; Catterall, W.A. Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels. Neuropharmacology, 2003, 44, 413-422.
91. Carter, A.J.; Grauert, M.; Pschorn, U.; Bechtel, W.D.; Bartmann-Lindholm, C.; Qu, Y.; Scheuer, T.; Catterall, W.A.; Weiser, T. Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL. Proc. Natl. Acad. Sci. USA, 2000, 97, 4944-4949.
92. Weiser, T.; Qu, Y.; Catterall, W.A.; Scheuer, T. Differential interaction of R-mexiletine with the local anesthetic receptor site on brain and heart sodium channel alpha-subunits. Mol. Pharmacol., 1999, 56, 1238-1244.
93. Wagner, L.E. 2nd.; Eaton, M.; Sabnis, S.S.; Gingrich, K.J. Meperidine and lidocaine block of recombinant voltage-dependent Na+ channels: evidence that meperidine is a local anesthetic. Anesthesiology, 1999, 91, 1481-1490.
94. Gauthereau, M.Y.; Salinas-Stefanon, E.M.; Cruz, S.L. A mutation in the local anaesthetic binding site abolishes toluene effects in sodium channels. Eur. J. Pharmacol., 2005, 528, 17-26.
95. Wagner, L.E. 2nd.; Gingrich, K.J.; Kulli, J.C.; Yang, J. Ketamine blockade of voltage-gated sodium channels: evidence for a shared receptor site with local anesthetics. Anesthesiology, 2001, 95, 1406-1413.
96. Wang, G.K.; Mitchell, J.; Wang, S.Y. Block of persistent late Na+ currents by antidepressant sertraline and paroxetine. J. Membr. Biol., 2008, 222, 79-90.
97. Wang, G.K.; Russell, C.; Wang, S.Y. State-dependent block of voltage-gated Na+ channels by amitriptyline via the local anesthetic receptor and its implication for neuropathic pain. Pain, 2004, 110, 166-174.
98. Sheets, P.L.; Gerner, P.; Wang, C.F.; Wang, S.Y.; Wang, G.K.; Cummins, T.R. Inhibition of Nav1.7 and Nav1.4 sodium channels by trifluoperazine involves the local anesthetic receptor. J Neurophysiol., 2006, 96, 1848-1859.
99. Wang, G.K.; Calderon, J.; Wang, S.Y. State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine. Mol. Pharmacol., 2008, 73, 940-948.
100. Wang, S.Y.; Mitchell, J.; Wang, G.K. Preferential block of inactivation- deficient Na+ currents by capsaicin reveals a non-TRPV1 receptor within the Na+ channel. Pain, 2007, 127, 73-83.
101. Desaphy, J.F.; Dipalma, A.; De Bellis, M.; Costanza, T.; Gaudioso, C.; Delmas, P.; George, A.L. Jr.; Camerino, D.C. Involvement of voltage-gated sodium channels blockade in the analgesic effects of orphenadrine. Pain, 2009, 142, 225-235.
102. Nau, C.; Wang, S.Y.; Strichartz, G.R.; Wang, G.K. Block of human heart hH1 sodium channels by the enantiomers of bupivacaine. Anesthesiology, 2000, 93, 1022-1033.
103. Nau, C.; Seaver, M.; Wang, S.Y.; Wang, G.K. Block of human heart hH1 sodium channels by amitriptyline. J. Pharmacol. Exp. Ther., 2000, 292, 1015-1023.
104. Wright, S.N. Irreversible block of human heart (hH1) sodium channels by the plant alkaloid lappaconitine. Mol. Pharmacol., 2001, 59, 183-192.
105. Guex, N.; Peitsch, M.C. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis, 1997, 18, 2714-2723.